Inactive Instrument

NVN Liquidation, Inc.

NOVN

US66988N2053

Investment Holding Companies

Delayed OTC Markets Other stock markets 03:32:31 2024-04-30 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.88%		-99.88%	-99.80%

Jan. 17	First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	CI
2023	Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc.	CI

Novan, Inc. Appoints Tomoko Maeda-Chubachi as Chief Medical Officer

August 24, 2021 at 09:00 am EDT

Novan, Inc. announced the appointment of Tomoko Maeda-Chubachi, MD, PhD, MBA as Chief Medical Officer. Dr. Maeda-Chubachi has served as Novan’s Senior Vice President, Medical since March of 2021 and Vice President, Medical Dermatology since joining the Company in September of 2017. Prior to joining the Company, Dr. Maeda-Chubachi served as senior medical director at GlaxoSmithKline.

Latest news about NVN Liquidation, Inc.

First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	Jan. 16	CI
Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc.	Dec. 19	CI
First Motion for Exclusivity Period Extension Approved For NVN Liquidation, Inc.	Nov. 30	CI
Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	Nov. 22	CI
First Motion for Exclusivity Period Extension Filed by NVN Liquidation, Inc.	Nov. 12	CI
Novan, Inc. has Changed its Name to NVN Liquidation, Inc	23-10-20	CI
Novan, Inc. Announces the Resignation of John M. Gay as Chief Financial Officer	23-09-27	CI
Novan, Inc. Announces the Resignation of John M. Gay as Secretary	23-09-27	CI
Ligand Pharmaceuticals Incorporated completed the acquisition of Substantially All of the Assets of Novan, Inc. for $12.2 million.	23-09-26	CI
Motion for Asset Sale Approved for Novan, Inc.	23-09-12	CI
Motion for Asset Sale Approved for Novan, Inc.	23-09-12	CI
Notice of selection of Successful Bidder Filed by Novan, Inc.	23-09-01	CI
Notice of selection of Successful Bidder Filed by Novan, Inc.	23-08-31	CI
Final DIP Financing Approved for Novan, Inc.	23-08-21	CI
Bidding Procedure Approved for Novan, Inc.	23-08-15	CI
Novan, Inc.(OTCPK:NOVN.Q) dropped from NASDAQ Composite Index	23-07-25	CI
Interim DIP Financing Approved for Novan, Inc.	23-07-21	CI
Novan, Inc.(NasdaqCM:NOVN) dropped from S&P TMI Index	23-07-20	CI
Motion for Joint Administration Approved for Novan, Inc.	23-07-19	CI
Sector Update: Health Care Stocks Slipping Late Monday	23-07-17	MT
Top Midday Decliners	23-07-17	MT
Sector Update: Healthcare Stocks Easing Monday Afternoon	23-07-17	MT
Novan Files for Chapter 11 Bankruptcy Protection, to Sell Nearly All Assets to Ligand Pharmaceuticals	23-07-17	MT
Novan Files Voluntary Chapter 11 Petition	23-07-17	MT
Motion for Asset Sale Filed by Novan, Inc.	23-07-17	CI

Chart NVN Liquidation, Inc.

Duration

Period

More charts

Company Profile

NVN Liquidation, Inc., formerly Novan, Inc., has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
SCREAMING EAGLE ACQUISITION CORP.	-3.96%	1.04B
OKLO INC.	-7.48%	1.03B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+22.32%	814M
E7 GROUP	+8.62%	675M
ARES ACQUISITION CORPORATION II	+1.77%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	+0.00%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M

Shell Companies

NVN Liquidation, Inc.

Equities

NOVN

US66988N2053

Investment Holding Companies

Novan, Inc. Appoints Tomoko Maeda-Chubachi as Chief Medical Officer

Latest news about NVN Liquidation, Inc.

Chart NVN Liquidation, Inc.

Company Profile

Sector Shell Companies